Clinical efficacy of transarterial chemoembolization combined with immunotherapy plus target therapy for advanced unresectable intrahepatic cholangiocarcinoma
10.3760/cma.j.cn115610-20211108-00551
- VernacularTitle:经肝动脉化疗栓塞联合免疫靶向治疗晚期不可切除肝内胆管细胞癌的临床疗效
- Author:
Hui ZHANG
1
;
Zhiyu CHEN
;
Yi GONG
;
Haisu DAI
;
Binbin TAN
;
Wei MU
;
Leida ZHANG
Author Information
1. 陆军军医大学第一附属医院肝胆外科，重庆 400038
- Keywords:
Biliary tract neoplasms;
Immunotherapy plus target therapy;
Transarterial chemoembolization;
Combination therapy;
Clinical efficacy
- From:
Chinese Journal of Digestive Surgery
2021;20(S2):37-40
- CountryChina
- Language:Chinese
-
Abstract:
Advanced intrahepatic cholangiocarcinoma(ICC) is one of the most common hepatic malignant tumors besides hepatocellular carcinoma, with occult onset, limited treatment and poor prognosis. Systemic treatment is a recommendable solution for advanced unresectable ICC. The authors reported the clinical experience of an ICC patient who underwent transarterial chemoembolization combined with immunotherapy plus target therapy.
